Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ikonisys bladder cancer test

This article was originally published in Clinica

Executive Summary

Ikonisys has received US FDA 510(k) market clearance for its automated bladder cancer test, oncoFISH, which, when used with the firm's robotic digital microscopy platform, Ikoniscope, enables faster testing of cells in urine to help detect the disease. Ikonisys' technology automates a standard but time-consuming laboratory technique, fluorescence in situ hybridisation (FISH), which identifies chromosome aberrations associated with various diseases. oncoFISH bladder detects aberrations for chromosomes 3, 7, 9, and 17 in cells in urine sediment to aid in the initial diagnosis of bladder cancer in patients with haematuria and the subsequent monitoring for tumour recurrence in patients previously diagnosed with bladder cancer. The test is expected to improve diagnostic accuracy, said the New Haven, Connecticut firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT047538

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel